Aching for Improvement: Review of the Gaps and Latest Advances in Osteoarthritis Pain and Other Chronic Pain Management
- CME / AMA PRA Category 1 Credit™
- MOC / ABIM MOC Part 2 Credit
- CNE / Nursing Contact Hours
- CPE / ACPE Contact Hours
- MIPS Improvement Activity Under MACRA
Chronic pain, including pain from osteoarthritis (OA), plagues more than half of older adults in the US. In order to help alleviate this pain, primary care physicians (PCPs), NPs, PAs, and pain specialists must be kept up to date with the recommendations for optimal assessment of, goal setting for, and monitoring of patients with OA pain and other chronic pain.
This activity, Aching for Improvement: Review of the Gaps and Latest Advances in Osteoarthritis Pain and Other Chronic Pain Management, will help clinicians appropriately tailor pain-management plans to their individual patients, including those in special populations, such as the elderly. PCPs, NPs, PAs, and pain specialists will better understand the safety and efficacy profiles of each of the available pain treatment options, along with the unique considerations one must take into account when treating more complex patients.
I. Welcome and Introductions
II. Strategies for diagnosis and initial management of OA and other chronic pain
III. Treatment of elderly patients with OQ and other chronic pain
IV. Emerging NGF inhibitors for the treatment of OA and other chronic pain
V. Concluding Remarks and Q&A
This activity is intended for PCPs, NPs, PAs, Pain Specialists, and additional clinicians who assess and manage patients with Osteoarthritis pain and other chronic pain.
This program is designed to address the following National Academy of Medicine (NAM,
formerly Institute of Medicine [IOM]) competencies: provide patient-centered care and employ evidence-based practice.
At the conclusion of this activity, learners should be able to demonstrate the ability to:
- Explain how to assess patients with OA pain and other chronic pain using current screening recommendations and tools
- Identify available strategies to facilitate optimal goal setting, and monitoring of patients with OA pain and other chronic pain
- Develop effective, personalized OA pain and other chronic pain treatment plans in special populations (e.g. elderly)
- Evaluate the safety and efficacy data with the novel nerve growth factor (NGF) inhibitors in clinical development for OA pain and other chronic pain
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Rockpointe. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Pharmacy Specialist, Pain Management
Director, PGY2 Pain Management and Palliative Care Residency
Owner, Vanguard Pain Management Consulting LLC
He is a Residency Director for a PGY-2 Pain and Palliative Care Pharmacy Residency program and strong advocate for expansion of clinical pharmacists with expertise in collaborative drug therapy management (CDTM) specific to pain management. Dr. Atkinson is the owner of Vanguard Pain Management Consulting, where he advises clients in managed care and the pharmaceutical industry. His research interests include opioid equivalencies, serum-level monitoring, and pain management in specialty disease states and the elderly.
Medical Director, Swedish Health System Pain Medicine and Services
Past President, American Academy of Pain Medicine
Dr. Stanos is board certified in physical medicine and rehabilitation and pain medicine by the American Board of Pain Medicine and by the American Board of Anesthesia.
Dr. Stanos is a Past President of the American Academy of Pain Medicine and serves on the Board of Directors of the American Board of Pain Medicine. He served as a panel member on the Service Delivery and Reimbursement work group for the National Pain Strategy, an invited consultant to the CDC for the CDC Opioid Guideline for Prescribing Opioids for Chronic Pain, and as a work group member for Healthy People 2020 and Healthy People 2030. He is active with the American Academy of Physical Medicine and Rehabilitation and has served as the co- chair of education for the Pain and Neuromuscular Council.
Dr. Stanos’ work also includes ongoing educational initiatives for primary care, pain medicine, and physical medicine specialists around the United States and abroad. Dr. Stanos has published numerous scientific articles and book chapters related to pain management. He has been involved in the development and publication of treatment guidelines related to rehabilitation approaches for chronic pain and low back pain conditions. He also serves on the editorial board for the journal Pain Medicine and as a reviewer for other pain and rehabilitation journals.
A Mayday Foundation Advocacy fellow in 2013, Dr. Stanos's advocacy has continued to focus on increasing awareness and access for inter-disciplinary biopsychosocially-based pain care for patients suffering with chronic pain. In 2014, the University of Washington Department of Pain Medicine awarded Dr. Stanos with the John J. Bonica, MD lecture. He has appeared on CNN, National Public Radio, Fox News, regional print, and television news covering various topics related to pain medicine and pain rehabilitation.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Timothy J. Atkinson, PharmD, BCPS, CPE: Consultant/Independent Contractor: Axial Healthcare, Inc.; Advisory Committee: Purdue Pharma, LP; Honoraria: Auburn
Steven P. Stanos, DO: Consultant/Independent Contractor: Pfizer, Salix, Sanofi
Non-faculty Content Contributors Disclosures
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Chelsey Goins, PhD; Ashley Marostica, MSN, RN, CCM; Kristin Delisi, NP; Lindsay Borvansky; Liddy Knight; Andrea Funk; Ashley Cann: Nothing to disclose
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Global Education Group’s Program Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
For information about ABIM MOC of this program, please email: email@example.com
NURSING CONTINUING EDUCATION
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
NURSE PRACTITIONER CONTINUING EDUCATION
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Rockpointe. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1 contact hour which includes 0.2 hours of pharmacology.
PHARMACIST ACCREDITATION STATEMENT
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PHARMACIST CREDIT DESIGNATION
This is a knowledge-based activity.
MIPS CREDIT DESIGNATION
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). In order to fulfill requirements for MIPS improvement activity, participants will need to fill out 2 brief follow-up surveys at 30- and 90-days post-activity.
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/MIPS CREDIT/MOC POINTS
Jointly provided by Global Education Group and Rockpointe Corporation
This program is supported through an educational grant from Pfizer Inc and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Ensuring Optimal Integration of the GLP-1 Receptor Agonists: Review of the Latest Advances and Current Gaps in Care
Credits 1.00 (60 min)
Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint
Credits 3.00 (3 hrs)